Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Genomic epidemiology of SARS-CoV-2 variants during the first two years of the pandemic in Colombia

  • Cinthy Jimenez-Silva
  • , Ricardo Rivero
  • , Jordan Douglas
  • , Remco Bouckaert
  • , Ch Julian Villabona-Arenas
  • , Katherine E. Atkins
  • , Bertha Gastelbondo
  • , Alfonso Calderon
  • , Camilo Guzman
  • , Daniel Echeverri-De la Hoz
  • , Marina Muñoz
  • , Nathalia Ballesteros
  • , Sergio Castañeda
  • , Luz H. Patiño
  • , Angie Ramirez
  • , Nicolas Luna
  • , Alberto Paniz-Mondolfi
  • , Hector Serrano-Coll
  • , Juan David Ramirez
  • , Salim Mattar
  • Alexei J. Drummond

    Producción científica: Contribución a revistaArtículo de Investigaciónrevisión exhaustiva

    Resumen

    Background: The emergence of highly transmissible SARS-CoV-2 variants has led to surges in cases and the need for global genomic surveillance. While some variants rapidly spread worldwide, other variants only persist nationally. There is a need for more fine-scale analysis to understand transmission dynamics at a country scale. For instance, the Mu variant of interest, also known as lineage B.1.621, was first detected in Colombia and was responsible for a large local wave but only a few sporadic cases elsewhere. Methods: To better understand the epidemiology of SARS-Cov-2 variants in Colombia, we used 14,049 complete SARS-CoV-2 genomes from the 32 states of Colombia. We performed Bayesian phylodynamic analyses to estimate the time of variants’ introduction, their respective effective reproductive number, and effective population size, and the impact of disease control measures. Results: Here, we detect a total of 188 SARS-CoV-2 Pango lineages circulating in Colombia since the pandemic’s start. We show that the effective reproduction number oscillated drastically throughout the first two years of the pandemic, with Mu showing the highest transmissibility (Re and growth rate estimation). Conclusions: Our results reinforce that genomic surveillance programs are essential for countries to make evidence-driven interventions toward the emergence and circulation of novel SARS-CoV-2 variants.

    Idioma originalInglés estadounidense
    Número de artículo97
    PublicaciónCommunications Medicine
    Volumen3
    N.º1
    DOI
    EstadoPublicada - dic. 2023

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. ODS 3: Salud y bienestar
      ODS 3: Salud y bienestar

    Áreas temáticas de ASJC Scopus

    • Salud pública, medioambiental y laboral
    • Medicina interna
    • Epidemiología
    • Medicina (miscelánea)
    • Evaluación y diagnóstico

    Huella

    Profundice en los temas de investigación de 'Genomic epidemiology of SARS-CoV-2 variants during the first two years of the pandemic in Colombia'. En conjunto forman una huella única.

    Citar esto